Literature DB >> 26049923

Myocardial perfusion pattern for stratification of ischemic mitral regurgitation response to percutaneous coronary intervention.

Parag Goyal1, Jiwon Kim, Attila Feher, Claudia L Ma, Sergey Gurevich, David R Veal, Massimiliano Szulc, Franklin J Wong, Mark B Ratcliffe, Robert A Levine, Richard B Devereux, Jonathan W Weinsaft.   

Abstract

OBJECTIVE: Ischemic mitral regurgitation (MR) is common, but its response to percutaneous coronary intervention (PCI) is poorly understood. This study tested the utility of myocardial perfusion imaging (MPI) for the stratification of MR response to PCI.
METHODS: MPI and transthoracic echocardiography (echo) were performed among patients undergoing PCI. MPI was used to assess stress/rest myocardial perfusion. MR was assessed via echo (performed before and after PCI).
RESULTS: A total of 317 patients with abnormal myocardial perfusion on MPI underwent echo 25±39 days before PCI. MR was present in 52%, among whom 24% had advanced (≥moderate) MR. MR was found to be associated with left ventricular (LV) chamber dilation on MPI and echo (both P<0.001). The magnitude of global LV perfusion deficits increased in relation to MR severity (P<0.01). Perfusion differences were greatest for global summed rest scores, which were 1.6-fold higher among patients with advanced MR versus those with mild MR (P=0.004), and 2.4-fold higher versus those without MR (P<0.001). In multivariate analysis, advanced MR was found to be associated with a fixed perfusion defect size on MPI [odds ratio 1.16 per segment (confidence interval 1.002-1.34), P=0.046], independent of LV volume [odds ratio 1.10 per 10 ml (confidence interval 1.04-1.17), P=0.002]. Follow-up via echo (1.0±0.6 years) demonstrated MR to decrease (≥1 grade) in 31% of patients and increase in 12% of patients. Patients with increased MR after PCI had more severe inferior perfusion defects on baseline MPI (P=0.028), whereas defects in other distributions and LV volumes were similar (P=NS).
CONCLUSION: The extent and distribution of single-photon emission computed tomography-evidenced myocardial perfusion defects impact MR response to revascularization. An increased magnitude of inferior fixed perfusion defects predicts post-PCI progression of MR.

Entities:  

Mesh:

Year:  2015        PMID: 26049923      PMCID: PMC4631658          DOI: 10.1097/MCA.0000000000000271

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  33 in total

1.  Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery.

Authors:  Martin Penicka; Hana Linkova; Otto Lang; Richard Fojt; Viktor Kocka; Marc Vanderheyden; Jozef Bartunek
Journal:  Circulation       Date:  2009-09-28       Impact factor: 29.690

2.  The impact of percutaneous coronary intervention on ischemic mitral regurgitation.

Authors:  Anna M Booher; Stanley J Chetcuti; David S Bach
Journal:  J Heart Valve Dis       Date:  2012-09

3.  Surgical treatment of moderate ischemic mitral regurgitation.

Authors:  Peter K Smith; John D Puskas; Deborah D Ascheim; Pierre Voisine; Annetine C Gelijns; Alan J Moskowitz; Judy W Hung; Michael K Parides; Gorav Ailawadi; Louis P Perrault; Michael A Acker; Michael Argenziano; Vinod Thourani; James S Gammie; Marissa A Miller; Pierre Pagé; Jessica R Overbey; Emilia Bagiella; François Dagenais; Eugene H Blackstone; Irving L Kron; Daniel J Goldstein; Eric A Rose; Ellen G Moquete; Neal Jeffries; Timothy J Gardner; Patrick T O'Gara; John H Alexander; Robert E Michler
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

4.  Percutaneous versus surgical revascularization in patients with ischemic mitral regurgitation.

Authors:  Duk-Hyun Kang; Byung Joo Sun; Dae-Hee Kim; Sung-Cheol Yun; Jong-Min Song; Suk Jung Choo; Cheol Hyun Chung; Jae-Kwan Song; Jae-Won Lee; Seong-Wook Park; Seung-Jung Park
Journal:  Circulation       Date:  2011-09-13       Impact factor: 29.690

5.  Outcomes of patients with ischemic mitral regurgitation undergoing percutaneous coronary intervention.

Authors:  Rayan Yousefzai; Navkaranbir Bajaj; Amar Krishnaswamy; Sachin S Goel; Shikhar Agarwal; Olcay Aksoy; Bhuvnesh Aggarwal; Valeria E Duarte; Abdel Anabtawi; Akhil Parashar; Nishtha Sodhi; James Thomas; Brian P Griffin; E Murat Tuzcu; Samir R Kapadia
Journal:  Am J Cardiol       Date:  2014-07-18       Impact factor: 2.778

6.  Coronary revascularization trends in the United States, 2001-2008.

Authors:  Andrew J Epstein; Daniel Polsky; Feifei Yang; Lin Yang; Peter W Groeneveld
Journal:  JAMA       Date:  2011-05-04       Impact factor: 56.272

7.  Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation.

Authors:  Jason S Chinitz; Debbie Chen; Parag Goyal; Sean Wilson; Fahmida Islam; Thanh Nguyen; Yi Wang; Sandra Hurtado-Rua; Lauren Simprini; Matthew Cham; Robert A Levine; Richard B Devereux; Jonathan W Weinsaft
Journal:  JACC Cardiovasc Imaging       Date:  2013-02

8.  Effect of myocardial perfusion pattern on frequency and severity of mitral regurgitation in patients with known or suspected coronary artery disease.

Authors:  Samuel C Volo; Jiwon Kim; Sergey Gurevich; Maya Petashnick; Polydoros Kampaktsis; Attila Feher; Massimiliano Szulc; Franklin J Wong; Richard B Devereux; Peter M Okin; Leonard N Girardi; James K Min; Robert A Levine; Jonathan W Weinsaft
Journal:  Am J Cardiol       Date:  2014-05-16       Impact factor: 2.778

9.  In patients with post-infarction left ventricular dysfunction, how does impaired basal rotation affect chronic ischemic mitral regurgitation?

Authors:  Concetta Zito; Maurizio Cusmà-Piccione; Lilia Oreto; Sonia Tripepi; Moemen Mohammed; Gianluca Di Bella; Gabriella Falanga; Giuseppe Oreto; Salvatore Lentini; Scipione Carerj
Journal:  J Am Soc Echocardiogr       Date:  2013-05-31       Impact factor: 5.251

10.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Authors:  Michael A Acker; Michael K Parides; Louis P Perrault; Alan J Moskowitz; Annetine C Gelijns; Pierre Voisine; Peter K Smith; Judy W Hung; Eugene H Blackstone; John D Puskas; Michael Argenziano; James S Gammie; Michael Mack; Deborah D Ascheim; Emilia Bagiella; Ellen G Moquete; T Bruce Ferguson; Keith A Horvath; Nancy L Geller; Marissa A Miller; Y Joseph Woo; David A D'Alessandro; Gorav Ailawadi; Francois Dagenais; Timothy J Gardner; Patrick T O'Gara; Robert E Michler; Irving L Kron
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245

View more
  3 in total

1.  Anticipating the Vicious Circle of Postinfarction Mitral Regurgitation: Imaging Insights.

Authors:  Jacob P Dal-Bianco; Philipp E Bartko; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2016-07       Impact factor: 7.792

2.  Right Ventricular Dysfunction Impairs Effort Tolerance Independent of Left Ventricular Function Among Patients Undergoing Exercise Stress Myocardial Perfusion Imaging.

Authors:  Jiwon Kim; Antonino Di Franco; Tania Seoane; Aparna Srinivasan; Polydoros N Kampaktsis; Alexi Geevarghese; Samantha R Goldburg; Saadat A Khan; Massimiliano Szulc; Mark B Ratcliffe; Robert A Levine; Ashley E Morgan; Pooja Maddula; Meenakshi Rozenstrauch; Tara Shah; Richard B Devereux; Jonathan W Weinsaft
Journal:  Circ Cardiovasc Imaging       Date:  2016-11       Impact factor: 7.792

3.  The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC.

Authors:  Andrew J S Coats; Stefan D Anker; Andreas Baumbach; Ottavio Alfieri; Ralph Stephan von Bardeleben; Johann Bauersachs; Jeroen J Bax; Serge Boveda; Jelena Čelutkienė; John G Cleland; Nikolaos Dagres; Thomas Deneke; Dimitrios Farmakis; Gerasimos Filippatos; Jörg Hausleiter; Gerhard Hindricks; Ewa A Jankowska; Mitja Lainscak; Christoph Leclercq; Lars H Lund; Theresa McDonagh; Mandeep R Mehra; Marco Metra; Nathan Mewton; Christian Mueller; Wilfried Mullens; Claudio Muneretto; Jean-Francois Obadia; Piotr Ponikowski; Fabien Praz; Volker Rudolph; Frank Ruschitzka; Alec Vahanian; Stephan Windecker; Jose Luis Zamorano; Thor Edvardsen; Hein Heidbuchel; Petar M Seferovic; Bernard Prendergast
Journal:  Eur Heart J       Date:  2021-03-18       Impact factor: 29.983

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.